The Cancer Breakthrough Boom
Engineered immune cells. Supercharged scans. Drug implants. Gene manipulators. Blood biopsies. Read how these breakthroughs are transforming cancer care.
University of California San Francisco
Give to UCSFEngineered immune cells. Supercharged scans. Drug implants. Gene manipulators. Blood biopsies. Read how these breakthroughs are transforming cancer care.
Heather Hervey-Jumper, MD, became director of UCSF’s Program in Medical Education for the Urban Underserved (PRIME-US) last summer to do work that inspires and sustains her.
A new treatment approach draws on research into the unique teenage brain.
Quantitative Biosciences Institute’s Nevan Krogan reflects back on the COVID-19 pandemic and how internal and external communications, funding and international partnerships all contributed to a speedy COVID-19 response.
UCSF School of Nursing Dean Catherien Gilliss, PhD, RN, FAAN announces plans to step out of the deanship at the end of December 2023.
Two UCSF scientists – James Gardner, MD, PhD, and Rebeca de Pavia Fróes Rocha, PhD – have received Pew awards for their work in immunology as part of a program that supports promising early-career investigators.
Two new oral polio vaccines will help limit the amount of new polio strains and outbreaks by genetically engineering weakened polio virus in the oral vaccine to reduce reversion to dangerous forms.
Caro Reyes, a project manager at UCSF’s Office of Communications, shares her story about her journey in managing chronic neuropathy, musculoskeletal pain and mobility issues. She discusses what her disability has taught her, and how workplaces can help accommodate staff with disabilities.
A new study shows that percutaneous coronary intervention can improve patient outcomes in communities with unmet needs.
UCSF researchers developed an approach to measure an over-the-counter allergy medication’s effectiveness in repairing brain damage from multiple sclerosis (MS), making it possible to also assess future therapies for the disorder.
Julia Adler-Milstein, PhD, has been appointed chief of the newly created Division of Clinical Informatics and Digital Transformation (DoC-IT) at UCSF. The new division will promote the integration and application of information technology to improve patient care.
Laws in many states require notifying women if they have dense breasts, a risk factor for breast cancer. But density shouldn’t be the only factor in determining whether supplemental screening is